pyrroles has been researched along with Raynaud Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abreu, J; Li, D; Tepper, SJ | 1 |
| Abou-Raya, A; Abou-Raya, S; Helmii, M | 1 |
| Kaburaki, J; Kuwana, M; Okazaki, Y | 1 |
1 review(s) available for pyrroles and Raynaud Disease
| Article | Year |
|---|---|
A Brief Review of Gepants.
Topics: Calcitonin Gene-Related Peptide Receptor Antagonists; Humans; Migraine Disorders; Pyridines; Pyrroles; Raynaud Disease | 2023 |
1 trial(s) available for pyrroles and Raynaud Disease
| Article | Year |
|---|---|
Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Topics: Atorvastatin; Double-Blind Method; Female; Fingers; Health Status; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pain; Pain Measurement; Pyrroles; Raynaud Disease; Scleroderma, Systemic; Severity of Illness Index; Skin Ulcer; Surveys and Questionnaires; Treatment Outcome | 2008 |
1 other study(ies) available for pyrroles and Raynaud Disease
| Article | Year |
|---|---|
Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis.
Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Atorvastatin; Cell Count; Cell Separation; Disease Progression; E-Selectin; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor 2; Flow Cytometry; Fluorescent Antibody Technique; Health Status; Heptanoic Acids; Humans; Immunoprecipitation; Middle Aged; Prospective Studies; Pyrroles; Raynaud Disease; Scleroderma, Systemic; Severity of Illness Index; Stem Cells; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2009 |